Homarylamine
Homarylamine (INN;[1] also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is a substituted phenethylamine. It is the N-methylated analog of MDPEA. Homoarylamine was patented as an antitussive in 1956,[2] but has never been used medically as such.
Clinical data | |
---|---|
Other names | 1,3-benzodioxolyl-N-methyl-5-ethanamine; 3,4-methylenedioxy-N-methyl-2-phenylethylamine; Norlobivine |
Routes of administration | Various |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H13NO2 |
Molar mass | 179.219 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Reactions
Reaction of homoarylamine with formaldehyde gives hydrastinine.
gollark: <:rustcode:747529842999689298>
gollark: <:bees:724389994663247974>
gollark: Good news, all apioentities of class φ and greater capable of interaction! My internet connection is back for some amount of time!
gollark: Well, see, it's spontaneously [REDACTED] critical subsystem apiofailure [BEES IN DATA].
gollark: The network links which link the network to the networks.
See also
- Hydrastine, an alkaloid derivative of homarylamine
References
- "International Non-Proprietary Names for Pharmaceutical Preparations" (PDF). Chronicle of the World Health Organization. 12 (3). 1958.
- U.S. Patent 2,820,739
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.